G. Ragupathi

发表

Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer

P. Livingston, D. Gin, J. Gardner, 2011, Expert review of vaccines.

Carbohydrate Vaccines Against Cancer

P. Livingston, G. Ragupathi, 2007 .

Cancer Vaccines Targeting Carbohydrate Antigens

P. Livingston, G. Ragupathi, 2006, Human vaccines.

Antibody inducing polyvalent cancer vaccines.

P. Livingston, G. Ragupathi, J. Gathuru, 2005, Cancer treatment and research.

Antibody-Inducing Cancer Vaccines Against Cell-Surface Carbohydrate Antigens

P. Livingston, G. Ragupathi, J. Gathuru, 2004 .

Impact of minimal tumor burden on antibody response to vaccination

N. Cheung, K. Panageas, P. Livingston, 2011, Cancer Immunology, Immunotherapy.

Quillaja saponin variants with central glycosidic linkage modifications exhibit distinct conformations and adjuvant activities

Derek S. Tan, J. Jiménez-Barbero, William E Walkowicz, 2016, Chemical science.

Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.

Derek S. Tan, P. Livingston, D. Gin, 2014, Bioorganic & medicinal chemistry.

Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probes.

M. Adams, P. Livingston, D. Gin, 2012, Journal of the American Chemical Society.

Deciphering structural elements of mucin glycoprotein recognition.

David F. Smith, Xuezheng Song, Yi Lasanajak, 2012, ACS chemical biology.

Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates.

O. Ouerfelli, S. Danishefsky, Y. Cho, 2006, Journal of the American Chemical Society.

Antibodies against Tumor Cell Glycolipids and Proteins, but Not Mucins, Mediate Complement-Dependent Cytotoxicity1

C. Musselli, K. Lloyd, P. Livingston, 2005, The Journal of Immunology.

Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology

Jason S. Lewis, S. Carlin, Nerissa T Viola-Villegas, 2013, The Journal of Nuclear Medicine.

Saponin QS-21 adjuvants in cancer vaccines

P. Livingston, D. Gin, J. Gardner, 2011 .

Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer.

S. Jagannath, M. Dhodapkar, D. Vesole, 2008, Blood.

Development of a minimal saponin vaccine adjuvant based on QS-21

Derek S. Tan, Jason S. Lewis, N. Pillarsetty, 2014, Nature chemistry.

Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T‐cell ligand

P. Chapman, N. Schrantz, Dianna Y. Wu, 2008, Immunology.

Design and synthesis of potent Quillaja saponin vaccine adjuvants.

M. Adams, P. Livingston, D. Gin, 2010, Journal of the American Chemical Society.

HLA-DR peptide occupancy can be regulated with a wide variety of small molecules

K. Szekeres, Sanjai Kumar, G. Blanck, 2016, Human vaccines & immunotherapeutics.

Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity.

R. Kerns, T. Coleman, P. Livingston, 2005, Vaccine.

Carbohydrate vaccines as immunotherapy for cancer

S. Slovin, Stacy J. Keding, G. Ragupathi, 2005, Immunology and cell biology.

Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.

M. Adams, K. Deng, P. Livingston, 2008, Angewandte Chemie.

Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial.

N. Cheung, S. Roberts, A. Mauguen, 2022, JAMA oncology.

Mitochondrial Ceramide-Rich Macrodomains Functionalize Bax upon Irradiation

John Calvin Reed, A. Haimovitz-Friedman, Z. Fuks, 2011, PloS one.

The known immunologically active components of Astragalus account for only a small proportion of the immunological adjuvant activity when combined with conjugate vaccines.

E. Kennelly, P. Leung, C. Lau, 2011, Planta medica.

The case for polyvalent cancer vaccines that induce antibodies

Philip S. Livingston, Govind Ragupathi, Philip Livingston, 2002, Expert review of vaccines.

The relative distribution of B35 alleles and their IEF isotypes in a HLA-B35-positive population.

S. Y. Yang, N. Cereb, G. Ragupathi, 1995, Tissue antigens.

Molecular basis of antibody binding to mucin glycopeptides in lung cancer

P. Hwu, Hongtao Yu, Bin Zhang, 2015, International journal of oncology.

Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.

M. Hollingsworth, J. Taylor‐Papadimitriou, H. Wandall, 2010, Cancer research.

Synthesis of sialyl Lewisa (sLea, CA19-9) and construction of an immunogenic sLea vaccine

Philip O. Livingston, Govind Ragupathi, Payal Damani, 2009, Cancer Immunology, Immunotherapy.

From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.

Qian Wan, Guangbin Yang, Ouathek Ouerfelli, 2009, Journal of the American Chemical Society.

Enzyme-linked immunosorbent assay for the phytotoxin thevetin.

K. Annapoorani, G. Ragupathi, C. Damodaran, 1993, Journal of immunoassay.

Mitochondrial Ceramide-Rich Macrodomains Functionalize Bax upon Irradiation

John Calvin Reed, A. Haimovitz-Friedman, Z. Fuks, 2011, PloS one.

Correction: Mitochondrial Ceramide-Rich Macrodomains Functionalize Bax upon Irradiation

John Calvin Reed, A. Haimovitz-Friedman, Z. Fuks, 2015, PLoS ONE.

Vaccin a conjugue acide polysialique-klh

P. Livingston, G. Ragupathi, 2000 .

1238. The Novel Semisynthetic Saponin Adjuvant TQL1055 Enhances the Antibody Response to Pertussis Vaccine with an Improved Tolerability Profile over QS-21

Philip S. Livingston, G. Ragupathi, C. Buzz, 2020 .

Mitochondrial Ceramide-Rich Macrodomains Functionalize Bax upon Irradiation

John Calvin Reed, A. Haimovitz-Friedman, Z. Fuks, 2011, PloS one.

Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.

M. Hollingsworth, J. Taylor‐Papadimitriou, H. Wandall, 2010, Cancer research.